CompletedNot Applicable

Neurological Fate, Prematurity and Genetic Susceptibility Factors

France27 participantsStarted 2020-03-09

Plain-language summary

This study could help identify aggravating or protective genetic polymorphisms associated with cerebral palsy. Populations of premature babies at different risk of cerebral palsy could thus be individualized with an impact on their monitoring and on the pathophysiological understanding of the processes leading to neurological lesions.

Who can participate

Age range5 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children born prematurely at term \<34 weeks between 2008 and 2015 * assessed at the age of 2 within the Growing Together Network in Pays de Loire * parental consent for the collection of data from their child and for intraoral sampling for the search for genetic factors. Exclusion Criteria: * children who died after the age of 2 * children who refused and / or whose parents refused to participate in the study

What they're measuring

Identify a polymorphism associated with the risk of developing cerebral palsy at 2 years in a regional population of premature infants of gestational age <34 weeks gestation.

Timeframe: 2 years

Trial details

NCT IDNCT04298346

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-09

View on ClinicalTrials.gov More Polymorphism, Restriction Fragment Length trials